3 ms·
If rich nations paid for poor nations to reach 95%+ vaccination levels, the virus would be tamed for everyone's benefit. With the prevailing scheme, in which r
by wombatmobile 5y ago
If rich nations paid for poor nations to reach 95%+ vaccination levels, the virus would be tamed for everyone's benefit.
With the prevailing scheme, in which rich nations fund high vax levels domestically, and allow poor nations to languish, the virus is always going to have reservoirs around the world in which it can mutate, thereby requiring new rounds of vaccination in the rich countries periodically.
The total cost of vaccinating the whole world in 1 year would be far less than the cost of infinite rolling booster programs. And yet, we do the latter.
Why? That's the secret sauce of the sustainable business model.
- isignal 5y agoThis is incorrect, cost of vaccines is not the only bottleneck. For example, India is currently manufacturing more vaccines than can can be sold to other countries. The bottleneck is apparently people on ground to get shots into arms. Most of the developed countries also used mRNA vaccines which needed low temperature refrigeration. Such facilities are cost prohibitive in poorer countries. Beyond all this, there’s a significant worldwide population of vaccine skeptics who will not take free vaccines at their doorstep if available.
- wombatmobile 5y agoYes, it is the total cost of vaccination programs ie the cost of the molecules + the cost of the rollout infrastructure. Vaccine hesitancy can’t be measured until a country has reached the point where everybody who wants to be inoculated has been, and there are still excess supplies. Australia is at 90% and still increasing, with plenty of incentives still left to try. The most effective drivers have been the new variants - delta and now omicron. Each time the infection rate has soared, the take up rate for vax has followed commensurately.
- katbyte 5y agoSome rich nations are having a hard time achieving 70%, 60% and so forth in many areas and vaccine availability and cost are not the limiting factor.